Reported Late Wednesday, Navidea Biopharmaceuticals Files Appeal In CRG Case
Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that on